About The Role

Group Company: Glenmark Pharmaceuticals Nordic AB Designation: Country Manager, Nordics Office Location: Malmo, Sweden Reporting To: V ice President, Northern Europe Cluster Position description: To lead the Nordics Business to exceed revenue and contribution budgets whilst developing the portfolio of products offered and building strong and useful business relationship throughout the market. Whilst ensuring the business remains within budgeted expenditure levels and Compliant with all Government legislation Responsibilities: 1 Financial health for the Nordics : Financially manage the Nordics business from a full P&L perspective. Accountable for all financial aspects of the business and the reporting (finance support provided) of the business on an ongoing basis accurately forecast and report all financial elements of the role in line with agreed procedures. •Topline sales achievement primary and secondary for the countries •Ensure the value and volume mix for the sales numbers to ensure that we have a demand led growth in the countries •Meet the budgeted GC/ EBIDTA projections yoy •Ensure budgeted annual and quarterly cash flow from the operations •Gain Rank and Market Share Growth in line with stated annual objectives •Manage expenses growth below topline growth •Undertaking timely and accurate annual budgeting, forecasting and business planning for sustainability 2 Drive sustainable growth: •Ensure Brand Development: Supervise on brand-marketing strategies for RX and OTC (incl. SFE) & maximize return on investment for the brands •Working closely with Product strategy and BD Group to capitalize on untapped business opportunities including filling in product gaps through in licensing and partnerships •Work with product strategy and regulatory to ensure that there is a robust middle and long term rolling filing strategy to ensure sustained revenue over time 3 Build organizational capability: •Build and supervise robust sales and marketing processes (incl. Tender/pricing, FC, SLOB). •Hire and retain best in class talent within the country •Effectively network to build, ensure that team members build positive relationships across the organization and work across a cross-functional matrix organization for quick decisions. •Develop relationships with all customers in the Nordics that allows business to achieve a beneficial multi-level relationship with all businesses. Results Expected/ Target: 1 Budget achievement, accurately forecast and report all financial elements of the role in line with agreed procedures 2 Market share of brands and products. In time submission of Business Cases. Evaluation of M&A. Value Now Activities. 3 Attrition. Development of the team to be recognized as best of bread. Networking to ensure easy access to all customers senior managers. % of time spent: 1 = 50%; 2 = 30%; 3 = 20% Educational qualifications preferred Degree: Educated to degree level or equivalent experience Experience: Minimum 5 years experience of the Nordics Generics Market, particularly the structure of the tender models, and preferably experience of the overall Pharma market in the Nordics. Hands on experience of having managed a major wholesale account previously. Knowledge & Skills: Good understanding of regulatory frameworks, pathways and reimbursement process/models for the country Resourceful, strategic and analytical thinker and creative problem solver Driven to deliver quality results on time and in a highly ethical and professional manner Excellent interpersonal, presentation, networking, analytical and negotiation skills Organized and logical, and at the same time with a high degree of flexibility to change direction when needed Good understanding of business operations management Behavioural Attributes: Experienced business manager with the ability to flex the style to suit the changing needs of the business. Talent identification and acquisition is a key skill. Training, motivating, leading and controlling are all fundamental constituents’ of the role Orther Requirements: H ands-on, all-rounder Knowledge of other European Generic markets would be advantageous but not essential